MicroRNA-222 Promotes the Proliferation of Pulmonary Arterial Smooth Muscle Cells by Targeting P27 and TIMP3
Author(s) -
Ying Xu,
Yihua Bei,
Shutong Shen,
Jialiang Zhang,
Yichao Lu,
Junjie Xiao,
Xinli Li
Publication year - 2017
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000480371
Subject(s) - cell growth , microrna , transfection , western blot , vascular smooth muscle , luciferase , small interfering rna , cancer research , proliferating cell nuclear antigen , cell , microbiology and biotechnology , endothelial stem cell , chemistry , biology , cell culture , gene , smooth muscle , endocrinology , in vitro , biochemistry , genetics
Aberrant vascular smooth muscle cell (VSMC) proliferation plays an important role in the development of pulmonary artery hypertension (PAH). Dysregulated microRNAs (miRNAs, miRs) have been implicated in the progression of PAH. miR-222 has a pro-proliferation effect on VSMCs while it has an anti-proliferation effect on vascular endothelial cells (ECs). As the biological function of a single miRNA could be cell-type specific, the role of miR-222 in pulmonary artery smooth muscle cell (PASMC) proliferation is not clear and deserves to be explored.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom